Development of the Hemomonitor with an alert system for the patient using blood componentes

• Autor(a) principal: Silva, Aline Bezerra
• Data de Publicação: 2022
• Outros Autores: Silva, Juliana de Oliveira Musse, Lima, Viviane Nascimento Brandão, Silva, Geydson Cruz da, Teles, Isabella Lima Dantas, Martins Júnior, João Amaury Lima, Santos Neto, Asclepíades José dos, Silva, Ângela Maria da, Oliveira, Adicinéia Aparecida de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/26300
• topic: Hemotherapy service; Blood component transfusion; Transfusion reaction; Software; Information systems; Clinical decision support systems.; Serviço de hemoterapia; Transfusão de componentes sanguíneos; Reação transfusional; Software; Sistemas de informação; Sistemas de apoio a decisões clínicas.; Servicio de hemoterapia; Transfusión de componentes sanguíneos; Reacción a la transfusión; Software; Sistemas de información; Sistemas de apoyo a la decisión clínica.

Objective: To develop the Hemomonitor software module with an alert system for monitoring patients using blood components. Methodology: This is an applied research carried out in a University Hospital, whose methodological trajectory followed three steps: 1) Characterization of the transfusion process at the study site; 2) Update on available software on the subject through a literature review; 3) Development of updated software based on specialized literature. Results: The flows of activities performed were triggered from the extraction of multivariate data from the systems, AGHUx and +Exames, used by the institution, to transform them into information. In addition, aiming at its operation, it was necessary to parameterize the alterations of the laboratory tests, to certify the HC prescription with the signature of the doctor responsible for the patient, to build a HC request sequencing, to allow the sharing of information and interface between the sectors, to standardize the supporting exams upon suspicion of transfusion, identify the patient's sample and the HC bag in an appropriate way with the legislation, parameterize the reports for the compatibility tests, allow traceability, parameterize changes in vital signs to establish a temporal link, define the audit trails, train teams in terms of speed of processes, efficiency and substantial use of resources. Conclusion: The implementation of the Hemomonitor module and its application in a pilot unit made it possible to observe that its use can improve the real-time monitoring and follow-up of patients using HC, helping to anticipate effective measures to mitigate TR.